HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

The ischemic metabolite lysophosphatidylcholine increases rat coronary arterial tone by endothelium-dependent mechanisms.

Abstract
Lysophosphatidylcholine (LPC), a hydrolysis product of phospholipid degradation, accumulates in the ischemic myocardium. Using isolated hearts or rat coronary septal arteries, we tested the impact of LPC in modulating basal function or the responses to vasoactive agents. Sustained perfusion of hearts with LPC augmented coronary perfusion pressure (CPP) and reduced left ventricular developed pressure (LVDP). By mechanisms that have yet to be identified, these effects on CPP and LVDP were exaggerated when LPC was removed from the perfusate. Although LPC (or its washout) had no direct effect on vascular tone in the isolated coronary artery, it selectively potentiated the receptor-coupled vasoconstrictor response to U-46619, a thromboxane A(2) mimetic. Interestingly, when LPC was washed out, the potentiation to U-46619 was even more pronounced. Both the immediate and residual effects of LPC were endothelium-dependent. EDHF was likely the sole mediator responsible for the direct effects of LPC on U-46619-vasoconstriction, whereas the augmented vasoconstrictor responses following LPC washout may in part be related to an increase in ET-1, and a striking reduction in the bioavailability of NO. Our data suggest that in addition to reducing the accumulation of LPC to prevent ischemia-reperfusion (I/R) damage, efforts targeting an improved endothelium-dependent regulation of vascular tone could be an attractive approach to limit the cardiac damage induced by I/R.
AuthorsRui Zhang, Ni Bai, Jeremy So, Ismail Laher, Kathleen M MacLeod, Brian Rodrigues
JournalJournal of molecular and cellular cardiology (J Mol Cell Cardiol) Vol. 47 Issue 1 Pg. 112-20 (Jul 2009) ISSN: 1095-8584 [Electronic] England
PMID19374907 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antihypertensive Agents
  • Biological Factors
  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Enzyme Inhibitors
  • Lysophosphatidylcholines
  • Sulfonamides
  • endothelium-dependent hyperpolarization factor
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • bosentan
  • NG-Nitroarginine Methyl Ester
Topics
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid (pharmacology)
  • Animals
  • Antihypertensive Agents (pharmacology)
  • Biological Factors (pharmacology)
  • Blood Pressure (drug effects)
  • Coronary Vessels (drug effects)
  • Endothelin Receptor Antagonists
  • Endothelin-1 (metabolism)
  • Endothelium, Vascular (metabolism)
  • Enzyme Inhibitors (pharmacology)
  • Lysophosphatidylcholines (pharmacology)
  • Male
  • NG-Nitroarginine Methyl Ester (pharmacology)
  • Rats
  • Rats, Wistar
  • Sulfonamides (pharmacology)
  • Vasoconstriction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: